UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$950M |
| 2 |
Linde
LIN
|
+$886M |
| 3 |
Amgen
AMGN
|
+$812M |
| 4 |
Pinduoduo
PDD
|
+$400M |
| 5 |
Advanced Micro Devices
AMD
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ametek
AME
|
+$475M |
| 2 |
Microsoft
MSFT
|
+$266M |
| 3 |
Amazon
AMZN
|
+$221M |
| 4 |
VMW
VMware, Inc
VMW
|
+$197M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 14.47% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.49% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAMI
1876
Acadian Asset Management
AAMI
$3.22B
| $1.14M | ﹤0.01% |
48,262
+2,791
| +6% | +$65.7K |
|
|
RDUS
1877
DELISTED
Radius Recycling
RDUS
| $1.14M | ﹤0.01% |
36,526
+2,472
| +7% | +$80.1K |
|
1878
indie Semiconductor
INDI
$786M
| $1.14M | ﹤0.01% |
107,599
+42,466
| +65% | +$379K |
|
1879
Syndax Pharmaceuticals
SNDX
$1.82B
| $1.13M | ﹤0.01% |
53,682
-4,413
| -8% | -$110K |
|
|
CDMO
1880
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $1.13M | ﹤0.01% |
60,331
+4,885
| +9% | +$80.2K |
|
|
DICE
1881
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $1.13M | ﹤0.01% |
39,422
+9,465
| +32% | +$280K |
|
1882
Cerence
CRNC
$403M
| $1.13M | ﹤0.01% |
+40,204
| New | +$1.03M |
|
1883
Westamerica Bancorp
WABC
$1.35B
| $1.13M | ﹤0.01% |
25,489
+3,455
| +16% | +$186K |
|
1884
Newmark Group
NMRK
$2.52B
| $1.13M | ﹤0.01% |
159,457
+8,576
| +6% | +$68.7K |
|
|
MRC
1885
DELISTED
MRC Global
MRC
| $1.13M | ﹤0.01% |
116,089
-7,730
| -6% | -$87.8K |
|
|
IMGN
1886
DELISTED
Immunogen Inc
IMGN
| $1.13M | ﹤0.01% |
293,790
+46,711
| +19% | +$199K |
|
1887
Caleres
CAL
$486M
| $1.13M | ﹤0.01% |
52,118
-37,870
| -42% | -$909K |
|
1888
Healthcare Services Group
HCSG
$1.5B
| $1.13M | ﹤0.01% |
81,211
+5,450
| +7% | +$71.8K |
|
|
RADI
1889
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $1.12M | ﹤0.01% |
76,389
+9,747
| +15% | +$132K |
|
1890
TriCo Bancshares
TCBK
$1.82B
| $1.12M | ﹤0.01% |
26,913
+2,253
| +9% | +$109K |
|
|
TBI
1891
Trueblue
TBI
$323M
| $1.12M | ﹤0.01% |
62,742
-1,086
| -2% | -$20.3K |
|
|
FLNA
1892
Filana Therapeutics
FLNA
$48.2M
| $1.12M | ﹤0.01% |
46,280
+14,542
| +46% | +$403K |
|
1893
St. Joe Company
JOE
$3.77B
| $1.12M | ﹤0.01% |
26,813
-4,698
| -15% | -$201K |
|
1894
Mirion Technologies
MIR
$3.75B
| $1.11M | ﹤0.01% |
130,379
+20,453
| +19% | +$162K |
|
|
SPTN
1895
DELISTED
SpartanNash
SPTN
| $1.11M | ﹤0.01% |
44,753
-3,620
| -7% | -$104K |
|
1896
Hillman Solutions
HLMN
$1.77B
| $1.1M | ﹤0.01% |
130,504
+14,963
| +13% | +$130K |
|
1897
Columbus McKinnon
CMCO
$557M
| $1.1M | ﹤0.01% |
29,546
+2,041
| +7% | +$74K |
|
|
SWTX
1898
DELISTED
SpringWorks Therapeutics
SWTX
| $1.1M | ﹤0.01% |
42,630
+15,712
| +58% | +$459K |
|
1899
United Microelectronic
UMC
$47.1B
| $1.09M | ﹤0.01% |
124,700
+87,600
| +236% | +$710K |
|
1900
International Money Express
IMXI
$356M
| $1.09M | ﹤0.01% |
42,371
+7,591
| +22% | +$184K |
|
Similar funds
UBS AM's Q1 2023 Portfolio in Review
As of Q1 2023, UBS AM held 2,762 positions worth $206B, up 8.3% from $191B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q1 2023 filing shows 231 new, 1,328 increased, 856 reduced and 85 closed positions. Its largest new stake was Amgen: 3,308,425 shares worth $800M. The largest sale was Ametek, an estimated $475M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q1 2023 buy was Amgen: 3,308,425 shares worth $800M.
- UBS AM added most to Abbott in Q1 2023, an estimated $950M increase.
- UBS AM's biggest Q1 2023 reduction was Ametek, cutting an estimated $475M.
- UBS AM fully exited SVB Financial Group in Q1 2023, selling an estimated $77.3M.
- UBS AM's ten largest holdings make up 22% of its $206B portfolio in Q1 2023.
- UBS AM opened 231 new positions and closed 85 in Q1 2023.
- UBS AM's portfolio value rose 8.3% quarter-over-quarter to $206B.
Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.